| Issue Date | Title | Author(s) |
| 17-Oct-2017 | Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens. | Eldering, M; Bompard, A; Miura, K; Stone, W; Morlais, I, et al |
| Oct-2020 | High Plasmodium infection intensity in naturally infected malaria vectors in Africa | Bompard, A; Da, DF; Yerbanga, SR; Morlais, I; Awono-Ambéné, PH, et al |
| 2-Sep-2015 | Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial | White, MT; Verity, R; Griffin, JT; Asante, KP; Owusu-Agyei, S, et al |
| 21-Oct-2018 | Informing target product profiles for a second-generation childhood malaria vaccine: a modelling study | Hogan, A; Winskill, P; Verity, R; Griffin, J; Ghani, A, et al |
| 13-Jul-2018 | Modelling population-level impact to inform target product profiles for childhood malaria vaccines | Hogan, AB; Winskill, P; Verity, R; Griffin, J; Ghani, A, et al |
| 24-Jan-2017 | Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa | Winskill, P; Walker, P; Griffin, J; Ghani, A; , et al |
| Dec-2021 | Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes | De Jong, RM; Meerstein-Kessel, L; Da, DF; Nsango, S; Challenger, JD, et al |
| 8-Mar-2021 | Predicting the public health impact of a malaria transmission-blocking vaccine | Challenger, J; Olivera Mesa, D; Da, DF; Yerbanga, RS; Lefèvre, T, et al |
| 3-Jul-2019 | Protein O-fucosyltransferase 2 is not essential for plasmodium berghei development | Sanz, S; Aquilini, E; Tweedell, RE; Verma, G; Hamerly, T, et al |
| 5-Nov-2015 | Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models | Penny, MA; Verity, RV; Bever, C; Sauboin, C; Galactionova, K, et al |
| 19-Jun-2018 | Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density | Sherrard-Smith, E; Sala, KA; Betancourt, M; Upton, LM; Angrisano, F, et al |
| 15-Oct-2019 | Transmission-blocking effects of primaquine and methylene blue suggest P. falciparum gametocyte sterilisation rather than effects on sex ratio | Bradley, J; Soumaré, HM; Mahamar, A; Diawara, H; Roh, M, et al |
| 23-Oct-2015 | Vaccine approaches to malaria control and elimination: Insights from mathematical models | White, MT; Verity, R; Churcher, TS; Ghani, AC; , et al |